Autism Is NOT Caused By Vaccines

Berg presents this as the first step in Dr. Combbre's protocol. He notes that autism involves chronic brain inflammation not related to a pathogen, and that 70% of autistic children have higher autoimmune markers. Vitamin D3 is used to dampen this autoimmune-like activity. The dose is significantly higher than the typical recommended daily allowance, reflecting a therapeutic intent. This is part of a broader strategy that also includes propolis and silica.

This is the second component of Dr. Combbre's protocol. Berg emphasizes that propolis is made by bees and has dual action: immune regulation and potent brain anti-inflammation. It is used alongside vitamin D3 and silica to address both the autoimmune and toxic aspects of autism.

Berg calls this the most important part of Dr. Combbre's protocol. The specific form recommended is monomethyl cylentrol (likely a silanol compound). The clip from Dr. Combbre reinforces this by explaining that injected aluminum is not eliminated by the kidneys and persists in immune cells, entering the brain. Silica provides a way to chelate and remove it. Dr. Combbre shares a case of a 17-year-old girl with severe depression since age 4, born in 2006 when she received many aluminum-containing vaccines. After taking silica, her depression improved by 85%, and her psychiatrist was able to reduce her medications. This anecdote is used to illustrate the potential of silica to reverse aluminum-related neurological issues.

This is an optional addition to the core protocol of vitamin D, propolis, and silica. Berg notes that Dr. Combbre adjusts the dose based on the child's response, cutting it down if it makes them too sleepy. The use of glycinate suggests a focus on the excitatory-inhibitory imbalance often seen in autism.

Berg adds this recommendation on top of Dr. Combbre's protocol, framing it as his own theoretical suggestion. He does not provide specific macronutrient ratios or duration. The idea aligns with emerging research on ketogenic diets for neurological disorders, but he is careful to note it is not a proven treatment for autism.

Berg begins by acknowledging the official narrative but then introduces the concept of vaccine adjuvants, specifically aluminum compounds, which are necessary to provoke an adequate immune response. He cites research showing aluminum is a neurotoxin that manifests in learning, memory, concentration, and speech deficits. He explains that injected aluminum can cross the blood-brain barrier with the help of immune cells, and that it persists in the body for an unexpectedly long time. He then presents a timeline from 1980 to 2023, correlating the rise in autism diagnoses (from 1 in 10,000 to 1 in 36) with the increase in the number of vaccine doses by age 6 (from 12 to 49) and the corresponding cumulative aluminum exposure (from 250 to 5,000 micrograms). He notes that the FDA requires warning labels for aluminum in parenteral feeding solutions but sets no safety limits for aluminum in vaccines. He also points out that many vaccine trials use aluminum-containing placebos or other aluminum-containing vaccines as the control group, which he argues invalidates the safety data because the control group is also exposed to the potential toxin. He further notes that countries with less aggressive vaccine schedules and the unvaccinated Amish community have very low autism rates. He suggests that a combination of genetic vulnerability and high aluminum exposure from vaccines could be 'the perfect storm' for developing autism.

Berg explains that a control group is supposed to receive no treatment so that any effects can be compared. However, in vaccine studies, the control group often receives an aluminum-containing placebo or another vaccine that also contains aluminum. This means both groups are exposed to aluminum, making it impossible to determine whether any adverse neurological outcomes are caused by the vaccine antigen or the adjuvant. He states that this practice 'completely cancels out those studies that did that,' implying that the safety data from such trials cannot be used to claim aluminum in vaccines is safe. This critique is central to his argument that the medical consensus is built on flawed evidence.

Berg introduces Dr. Combbre as a neurologist who has been treating autism since 2014. The protocol is based on the understanding that autism involves chronic brain inflammation not caused by a microbe, and that 70% of autistic children have higher levels of autoimmune diseases. The first component is vitamin D3 at 10,000 IU, which helps create a calming effect on an overactive immune system. The second is propolis, a bee-derived substance that regulates a dysfunctional immune system and acts as a potent anti-inflammatory for the brain. The third and 'most important' is an oral silica supplement called monomethyl cylentrol, given at 100-200 mg three times a day. Silica binds to aluminum, and both are then eliminated by the kidneys. If the child has hyperactivity, 4 g of glycinate is added to calm the nervous system, with adjustments if it causes excessive daytime sleepiness. Berg also recommends a low-carb diet to increase ketones for brain support, though he frames this as theory. A clip from Dr. Combbre reinforces the protocol, sharing a case of a 17-year-old girl with severe depression since age 4, born in 2006 and exposed to many aluminum-containing vaccines, who improved 85% after taking silica, allowing her psychiatrist to reduce her medications.